肾性贫血是慢性肾功能衰竭(CRF)患者最常见的并发症,其发生率高达90%。贫血除造成多器官的氧供不足外,更重要的是可能诱发或加重多脏器功能损伤,如心肌肥大、心衰、肾功能进行性恶化等,严重影响了患者的生活质量及预后。使用重组人类促红细胞生成素(rHuEPO)大大改善了肾性贫血 Renal anemia is the most common complication of patients with chronic renal failure (CRF), with a high incidence of up to 90%. In addition to anemia caused by multiple organ oxygen deficiency, more importantly, may induce or aggravate multiple organ dysfunction, such as myocardial hypertrophy, heart failure, progressive deterioration of renal function, seriously affecting the quality of life of patients and prognosis. Renal anemia has been greatly improved using recombinant human erythropoietin (rHuEPO)